Tokyo, Japan

Toichi Suzuki

This inventor holds 1 USPTO granted patent. Top assignee: Kureha Kagaku Kogyo Kabushiki Kaisha. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toichi Suzuki. Retrieved from https://idiyas.com/inventor/toichi-suzuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toichi Suzuki: Innovator in Immunoregulation

Introduction

Toichi Suzuki is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of immunoregulation. His innovative work has led to the development of a unique immunoregulator that has potential applications in medical science.

Latest Patents

Toichi Suzuki holds a patent for an immunoregulator comprising a derivative of estradiol. This patent, which is represented by the formula (I), describes an immunoregulator that has a minimal impact on non-specific immunoreactions while providing a specific influence on immunoreactions against an isoantibody. This innovation is crucial for advancing therapeutic strategies in immunology.

Career Highlights

Toichi Suzuki is associated with Kureha Kagaku Kogyo Kabushiki Kaisha, a company that focuses on advanced chemical products and solutions. His work at this organization has been instrumental in pushing the boundaries of immunological research and development.

Collaborations

Some of his notable coworkers include Humio Tamura and Kiro Asano. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Toichi Suzuki's innovative work in immunoregulation exemplifies the impact of dedicated research and development in the field of medicine. His contributions continue to influence the landscape of immunological therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…